Defunct Company
Total Trials
4
As Lead Sponsor
As Collaborator
0
Total Enrollment
210
NCT00103350
Safety of TG100-115 for Heart Attack Treated With Angioplasty
Phase: Phase 1/2
Role: Lead Sponsor
Start: Jan 31, 2005
Completion: Jan 31, 2008
NCT00414999
A Phase 1 Safety Study of TG100801 Eye Drops in Healthy Volunteers
Phase: Phase 1
Start: Nov 30, 2006
Completion: Feb 28, 2007
NCT00509548
Open-Label, Pilot Study of TG100801 in Patients With Choroidal Neovascularization Due to AMD
Phase: Phase 2
Start: Jul 31, 2007
Completion: Mar 31, 2008
NCT00631462
A Dose-escalation Study of the Safety and Tolerability of Orally Administered TG101348 in Patients With Myelofibrosis
Start: Jan 31, 2008
Completion: Oct 31, 2009